Merck to Acquire ArQule, Advancing Leadership in Oncology
Go back to Merck to Acquire ArQule, Advancing Leadership in Oncology| Arqule, Inc. (NASDAQ: ARQL) | Delayed: 20.00 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $20.00 | 52 Week High | $2.53 | |||
| Open | $22.46 | 52 Week Low | $1.20 | |||
| Day High | $20.00 | P/E | N/A | |||
| Day Low | $20.00 | EPS | $-0.38 | |||
| Volume | 447,432 | |||||
| Merck & Co. (NYSE: MRK) | Delayed: 152.20 +17.03 (12.60%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $135.17 | 52 Week High | $65.46 | |||
| Open | $146.94 | 52 Week Low | $47.97 | |||
| Day High | $153.50 | P/E | 103.54 | |||
| Day Low | $144.90 | EPS | $1.47 | |||
| Volume | 32,714,963 | |||||
